Xembify

Xembify is a human normal immunoglobulin solution used for immune system support. It provides passive immunity through concentrated antibodies. This therapy is administered subcutaneously for broad immune protection. Ideal for patients requiring immunoglobulin replacement.

Xembify is used to treat primary immunodeficiency disorders in patients who lack sufficient antibodies. It helps strengthen the immune system by providing antibodies from healthy donors. This therapy is also used for certain autoimmune conditions where the immune system attacks healthy tissues. It supports the body’s ability to fight infections and maintain health.

Xembify works by supplementing or replacing missing antibodies in the bloodstream. This can help reduce the frequency and severity of infections in patients with immune deficiencies. Patients may experience improved energy levels and overall well-being as their immune function stabilizes. The effects are typically gradual and build over time with regular use.

Xembify should be handled with care to avoid contamination. It is typically stored refrigerated but should not be frozen. Patients should follow their healthcare provider’s instructions for administration and monitoring. Report any unusual reactions, such as swelling or redness at the injection site, to a medical professional promptly.

Xembify may interact with live vaccines, potentially reducing their effectiveness. It is not known to interact with most medications, but patients should inform their doctor about all current treatments. Avoid mixing with other intravenous solutions unless directed by a healthcare provider. Alcohol and certain foods do not typically interfere with its use.